ID23175A - Penggunaan benzopiranol untuk mengobati gangguan syaraf - Google Patents

Penggunaan benzopiranol untuk mengobati gangguan syaraf

Info

Publication number
ID23175A
ID23175A IDW990097A ID979900A ID23175A ID 23175 A ID23175 A ID 23175A ID W990097 A IDW990097 A ID W990097A ID 979900 A ID979900 A ID 979900A ID 23175 A ID23175 A ID 23175A
Authority
ID
Indonesia
Prior art keywords
benzopiranol
nerve disorders
treat nerve
treat
disorders
Prior art date
Application number
IDW990097A
Other languages
English (en)
Indonesian (id)
Inventor
Parsons Andrew
Thompson Mervyn
Upton Neil
Evans John Morris
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID23175A publication Critical patent/ID23175A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW990097A 1996-09-18 1997-09-15 Penggunaan benzopiranol untuk mengobati gangguan syaraf ID23175A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment

Publications (1)

Publication Number Publication Date
ID23175A true ID23175A (id) 2000-03-23

Family

ID=10800127

Family Applications (2)

Application Number Title Priority Date Filing Date
IDW990097A ID23175A (id) 1996-09-18 1997-09-15 Penggunaan benzopiranol untuk mengobati gangguan syaraf
IDP973201A ID19542A (id) 1996-09-18 1997-09-16 Pengobatan baru

Family Applications After (1)

Application Number Title Priority Date Filing Date
IDP973201A ID19542A (id) 1996-09-18 1997-09-16 Pengobatan baru

Country Status (30)

Country Link
EP (1) EP0939630B1 (es)
JP (1) JP2001500520A (es)
KR (1) KR20000036184A (es)
CN (1) CN1230885A (es)
AP (1) AP9901473A0 (es)
AR (1) AR008838A1 (es)
AT (1) ATE270102T1 (es)
AU (1) AU730465B2 (es)
BG (1) BG103252A (es)
BR (1) BR9712030A (es)
CA (1) CA2266681A1 (es)
DE (1) DE69729735T2 (es)
DZ (1) DZ2311A1 (es)
EA (1) EA199900306A1 (es)
ES (1) ES2223075T3 (es)
GB (1) GB9619492D0 (es)
HU (1) HUP9904638A3 (es)
ID (2) ID23175A (es)
IL (1) IL128786A0 (es)
MA (1) MA24321A1 (es)
NO (1) NO991292D0 (es)
NZ (1) NZ334271A (es)
OA (1) OA10998A (es)
PE (1) PE109898A1 (es)
PL (1) PL332313A1 (es)
SK (1) SK35199A3 (es)
TR (1) TR199900527T2 (es)
UY (1) UY24717A1 (es)
WO (1) WO1998011890A1 (es)
ZA (1) ZA978359B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
MX2010013313A (es) * 2008-06-05 2011-05-30 Minster Res Ltd Tratamientos novedosos.
WO2009147441A2 (en) * 2008-06-05 2009-12-10 Minster Research Limited Novel treatments
WO2011067607A1 (en) * 2009-12-03 2011-06-09 Minster Research Ltd Treatment of infectious diseases
CA2774715C (en) 2009-07-27 2018-04-03 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
US20130018091A1 (en) * 2009-12-03 2013-01-17 Peter Blower Treatment of allodynia and hyperalgesia
CN103096977B (zh) 2010-07-02 2017-02-15 吉利德科学公司 作为离子通道调节剂的稠杂环化合物
CA2834164A1 (en) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused benzoxazinones as ion channel modulators
NO3175985T3 (es) 2011-07-01 2018-04-28
TWI478908B (zh) 2011-07-01 2015-04-01 Gilead Sciences Inc 作為離子通道調節劑之稠合雜環化合物
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
DE69524871T2 (de) * 1994-06-10 2002-08-22 Smithkline Beecham Plc Benzopyrans und deren verwendung als therapeutische mittel
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
JP2001500520A (ja) 2001-01-16
EA199900306A1 (ru) 1999-08-26
GB9619492D0 (en) 1996-10-30
BG103252A (en) 1999-09-30
DZ2311A1 (fr) 2002-12-28
PL332313A1 (en) 1999-08-30
OA10998A (en) 2003-03-04
HUP9904638A2 (hu) 2001-05-28
BR9712030A (pt) 1999-08-24
AR008838A1 (es) 2000-02-23
EP0939630B1 (en) 2004-06-30
AU730465B2 (en) 2001-03-08
NZ334271A (en) 2001-03-30
DE69729735D1 (de) 2004-08-05
CN1230885A (zh) 1999-10-06
UY24717A1 (es) 2001-08-27
MA24321A1 (fr) 1998-04-01
IL128786A0 (en) 2000-01-31
AU4704797A (en) 1998-04-14
CA2266681A1 (en) 1998-03-26
HUP9904638A3 (en) 2001-08-28
TR199900527T2 (xx) 1999-06-21
NO991292L (no) 1999-03-17
KR20000036184A (ko) 2000-06-26
SK35199A3 (en) 2000-07-11
DE69729735T2 (de) 2005-07-14
ZA978359B (en) 1999-03-17
ID19542A (id) 1998-07-23
AP9901473A0 (en) 1999-03-31
EP0939630A1 (en) 1999-09-08
ES2223075T3 (es) 2005-02-16
ATE270102T1 (de) 2004-07-15
WO1998011890A1 (en) 1998-03-26
NO991292D0 (no) 1999-03-17
PE109898A1 (es) 1999-03-21

Similar Documents

Publication Publication Date Title
EE9900607A (et) Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks
IL134851A0 (en) Prostaglandin agonists and their use to treat bone disorders
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
EP0748219B8 (en) Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
PT861081E (pt) Utilizacao de epinastina para o tratamento de dores
EP1063990A4 (en) THERAPY FOR ESTROGEN RELATED DISORDERS
ID18679A (id) Penggunaan terapi lanjutan
ZA958725B (en) Treatment of disorders with duloxetine
ID23175A (id) Penggunaan benzopiranol untuk mengobati gangguan syaraf
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
PL345110A1 (en) Aza-heterocyclic compounds used to treat neurological disorders and hair loss
HK1112738A1 (en) Arylsulfonamides and analogues as well as use for the treatment of neuro- degenerative disorders
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DE69518438D1 (de) Behandlung von übereregten nervenzellenfunktionen
NO974569D0 (no) Benzamider for behandling av neurodegenerative forstyrrelser
IL131347A0 (en) Treatment of skin disorders
NO982562D0 (no) Sammensetning for behandling av smerte
FI952953A0 (fi) Aineita metabolisten luustosairauksien hoitamiseen
ZA9610134B (en) The use of 1-hydroxy-2-pyridones for the treatment of mucosal disorders which are difficult to treat
UA25221A (uk) Спосіб лікуваhhя розладів цеhтральhої hервової системи
DK82798A (da) Treatment of GABA-uptake related disorders